News & Media

News Updates

INBS Showcases Rapid, Non-Invasive Drug Testing in Remote Australia

Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment

NEW YORK, May 19, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “Council”) using its Intelligent Fingerprinting Drug Screening System (the…

How Far Back Does Fingerprint Drug Testing Go

How Far Back Does Fingerprint Drug Testing Go?

As workplace safety and compliance standards rise, more organizations are evaluating how drug testing is conducted and when it can detect use. One of the most common questions from health and safety teams is: how far back does fingerprint drug testing go? The answer lies in the science behind detection windows and why shorter, more…

Global Adoption of Fingerprint Drug Testing

Intelligent Bio Solutions Accelerates Global Adoption of Fingerprint Drug Testing

NEW YORK, May 15, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced recent growth highlights across its global operations, driven by new account acquisitions, expansion into new testing areas and sectors, and continued penetration into safety-critical industries. The Company’s total…

INBS Q3 2025 Financial Results and Key Achievements

Intelligent Bio Solutions Announces Fiscal Q3 2025 Financial Results and Key Operational Achievements

NEW YORK, May 13, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for the fiscal third quarter and nine months ended March 31, 2025, and provided a business update.  The Company delivered a strong quarter of…

Workplace Drug Testing Legal and Ethical Considerations

Workplace Drug Testing: Legal and Ethical Considerations

Workplace drug testing protects employee well-being, reduces operational risk, and supports compliance. Testing programs must combine legal awareness with ethical responsibility to be effective and respected. As global attitudes toward drug use continue to evolve and regulations shift, employers must navigate a complex and often fragmented landscape. Responsible employers build testing programs that follow local…

INBS Drives Global Growth Through Multilingual Digital Expansion

Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion

NEW YORK, May 06, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of three new localized websites in Arabic, Italian, and Spanish. This rollout supports the Company’s global growth plans and international sales expansion by opening digital and…

drug and alcohol misuse

The Real Cost of Workplace Drug Testing

In high-risk industries like construction, logistics, transport, manufacturing, and mining, the consequences of drug and alcohol misuse extend far beyond the individual. Even a single incident involving an impaired worker can have devastating consequences, with the potential for injury, operational disruption, and exposing companies to costly legal and reputational fallout. While some employers hesitate to…

Latin-American-Spanish

Intelligent Bio Solutions Expands Global Reach with Latin American Spanish Language Integration into Drug Screening System

NEW YORK, April 22, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the integration of Latin American Spanish into its Intelligent Fingerprinting Drug Screening System (the “System”). The enhancement allows users to operate the System in English, Arabic, and…

Fingerprint Drug Testing

The History of Fingerprint Drug Testing

Testing for illicit drug use has been readily available since the 1960s. Initially, those suspected of drug use would be required to submit a blood, hair, urine, or saliva sample for analysis. Of these drug screening methods, only urine and saliva remain suitable for routine workplace drug screening due to their speed and convenience. Although…

Fingerprint Drug Testing Demo

Intelligent Fingerprinting Drug Testing Demo

Discover how the Intelligent Fingerprinting Drug Testing Solution works via our easy-to-follow fingerprint drug testing demo. The Intelligent Fingerprinting Drug Screening System is quick and easy to use, detecting commonly abused drugs via the fingertips. Sample collection takes less than a minute, and results are available within ten minutes. The system’s ease of use and…

Arabic

Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System

NEW YORK, March 31, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has integrated Arabic as the second international language to its Intelligent Fingerprinting Drug Screening System as part of the Company’s multilingual upgrade. The addition of Arabic…

INBS Continues Expansion with Partnership in Spain and Andorra

Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra

NEW YORK, March 27, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has expanded access to its fingerprint drug testing in Spain and Andorra through a strategic collaboration with Detecto, a division of Spanish distributor MTB Distribuciones Tecnologicas SL (“MTB”). MTB established…

US Patent

Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned entry into multi-billion dollar U.S. market in 2025 NEW YORK, March 26, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent,…

INBS' FDA Clearance Process Remains on Track for U.S. Launch

Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch

NEW YORK, March 25, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today provided shareholders with a status update on the FDA clearance process for its Intelligent Fingerprint Drug Screening System, which remains on track for launch in the U.S. in 2025…

How Does Fingerprint Drug Testing Compare to Urine and Saliva?

How Does Fingerprint Drug Testing Compare to Urine and Saliva?

Traditional drug testing methods can be intrusive, undignified, and uncomfortable for both test takers and administrators. The Intelligent Fingerprinting Drug Screening System detects commonly abused drugs via fingertip sweat analysis, eliminating the need for invasive and unpleasant urine, saliva, or blood collection. Fingerprint sweat sample collection takes seconds – the donor simply presses all ten…

Media

Media Contact

info@ibs.inc